{"log_id": 1141820833147558750, "direction": 0, "words_result_num": 35, "words_result": [{"probability": {"variance": 0.029468, "average": 0.848083, "min": 0.36217}, "location": {"width": 1190, "top": 267, "height": 45, "left": 214}, "words": "能需要减少瑞格州奈的用药剂量。在一研究中,瑞格列上产十贝齐和CYP3A4排制训康唑合用显示出"}, {"probability": {"variance": 0.019705, "average": 0.910965, "min": 0.497231}, "location": {"width": 868, "top": 324, "height": 41, "left": 214}, "words": "更的降作用,瑞格到东AUC增加19.4倍,半衰期从1.3小时延长到6.1小时"}, {"probability": {"variance": 0.04279, "average": 0.880804, "min": 0.37538}, "location": {"width": 299, "top": 383, "height": 31, "left": 260}, "words": "甲氧每日两,每次"}, {"probability": {"variance": 0.009516, "average": 0.903346, "min": 0.683546}, "location": {"width": 751, "top": 376, "height": 34, "left": 660}, "words": "是一种弱CYP2C8抑割剂,与瑞格列(单剂0.5mg报,可使塌"}, {"probability": {"variance": 0.042032, "average": 0.856209, "min": 0.37376}, "location": {"width": 1197, "top": 429, "height": 45, "left": 212}, "words": "格奈AUC,Cmx和生物半衰有轻微的增:分别为1.6倍,1.4倍和12倍,血糖水加无显的统计学"}, {"probability": {"variance": 0.029195, "average": 0.848649, "min": 0.390181}, "location": {"width": 1203, "top": 479, "height": 50, "left": 212}, "words": "异。这些缺少药效学结果的数据系根据消洛奈息剂最治疗获得于尚无瑞格列余剂量于0.25mg与印算"}, {"probability": {"variance": 0.037009, "average": 0.86884, "min": 0.360757}, "location": {"width": 1192, "top": 536, "height": 45, "left": 217}, "words": "卡啶介于320rg的合用安全性数据,此避免将格列奈甲卡氨嘧啶合用如果必须合用,成密"}, {"probability": {"variance": 0.030151, "average": 0.881505, "min": 0.467744}, "location": {"width": 498, "top": 600, "height": 34, "left": 210}, "words": "监渡者的血糖水平,并进行严密的临庆监测"}, {"probability": {"variance": 0.025788, "average": 0.890738, "min": 0.354117}, "location": {"width": 1142, "top": 648, "height": 43, "left": 260}, "words": "刘裙平是一种CYP3A4强导剂,也是CYP2C8诱导,在瑞格列奈的代谢过中同时起诱导科排制"}, {"probability": {"variance": 0.027058, "average": 0.906068, "min": 0.578325}, "location": {"width": 118, "top": 712, "height": 29, "left": 214}, "words": "使用利福平"}, {"probability": {"variance": 0.039721, "average": 0.777787, "min": 0.373442}, "location": {"width": 957, "top": 703, "height": 41, "left": 454}, "words": "先期治打7大,然与瑞格列(单利4mng)在第7元时用,AC降了50%这是"}, {"probability": {"variance": 0.029004, "average": 0.879039, "min": 0.400547}, "location": {"width": 1197, "top": 758, "height": 43, "left": 212}, "words": "诱导和抑习作用的共同结)在最后次服用利平24小时后服用瑞格列,瑞格训奈的UC学低了80%(单"}, {"probability": {"variance": 0.034832, "average": 0.866711, "min": 0.503296}, "location": {"width": 121, "top": 820, "height": 29, "left": 212}, "words": "独涛导作用"}, {"probability": {"variance": 0.029054, "average": 0.904073, "min": 0.359192}, "location": {"width": 1128, "top": 868, "height": 41, "left": 260}, "words": "利福平与墙格列合可能会降低瑞列奈的用药剂,应严密监患者在开始使用利福平(快速"}, {"probability": {"variance": 0.025979, "average": 0.906014, "min": 0.418396}, "location": {"width": 1203, "top": 922, "height": 43, "left": 210}, "words": "增加(泥合抑制和诱导〕和停用利福平(单独诱导以及停利福平约1周后,其导作用消失时的血糖"}, {"probability": {"variance": 0.015172, "average": 0.91783, "min": 0.526375}, "location": {"width": 493, "top": 984, "height": 34, "left": 214}, "words": "平。并据血糖水平调节瑞格列奈的使用剂量"}, {"probability": {"variance": 0.021773, "average": 0.919905, "min": 0.375525}, "location": {"width": 920, "top": 1039, "height": 34, "left": 262}, "words": "点拉舞素是一种CYP3A4强制剂,以每日两次,每次250mg剂最与格列(单"}, {"probability": {"variance": 0.032467, "average": 0.790205, "min": 0.556808}, "location": {"width": 121, "top": 1037, "height": 29, "left": 1290}, "words": "同服,可使"}, {"probability": {"variance": 0.044172, "average": 0.815745, "min": 0.360281}, "location": {"width": 1144, "top": 1094, "height": 34, "left": 210}, "words": "瑜格列袋饰暴露量有微弱的增加增加14,C增加1.倍)清AUC平均值增15倍"}, {"probability": {"variance": 0.026338, "average": 0.869585, "min": 0.538105}, "location": {"width": 134, "top": 1155, "height": 27, "left": 212}, "words": "鲁加1.5倍"}, {"probability": {"variance": 0.012218, "average": 0.915428, "min": 0.606925}, "location": {"width": 274, "top": 1208, "height": 31, "left": 258}, "words": "用瑞格列奈(单次给药"}, {"probability": {"variance": 0.051751, "average": 0.800979, "min": 0.360066}, "location": {"width": 792, "top": 1203, "height": 38, "left": 616}, "words": "铜同时服CYP3点4强抑制青康(日200g上可在一范围科加"}, {"probability": {"variance": 0.017936, "average": 0.904191, "min": 0.547273}, "location": {"width": 820, "top": 1263, "height": 31, "left": 210}, "words": "溃洛到的暴露量(ALC增加1.2倍,C1增加1.6倍),血变化低于8%"}, {"probability": {"variance": 0.031785, "average": 0.881697, "min": 0.37307}, "location": {"width": 1085, "top": 1318, "height": 36, "left": 258}, "words": "瑞格列茶与西米替、鞘苯地平或辛伐他汀合用,所有CYP3A4作用底物均显著业格外的"}, {"probability": {"variance": 0.00536, "average": 0.942, "min": 0.817908}, "location": {"width": 98, "top": 1379, "height": 29, "left": 210}, "words": "刀学参数"}, {"probability": {"variance": 0.032571, "average": 0.87865, "min": 0.357826}, "location": {"width": 1137, "top": 1420, "height": 43, "left": 260}, "words": "在健康志中进行的药物相互作用研究发现瑞格外杂对地高、张碱科法华林的代动学性"}, {"probability": {"variance": 0.043236, "average": 0.834135, "min": 0.377758}, "location": {"width": 612, "top": 1489, "height": 27, "left": 214}, "words": "北在与瑞格列奈合使用时,无需调整这些药的量"}, {"probability": {"variance": 0.039603, "average": 0.862294, "min": 0.364783}, "location": {"width": 1133, "top": 1526, "height": 47, "left": 260}, "words": "在避志者中开展的一项药代动学研究表明:合用口服避孕药乙外辨二醇具"}, {"probability": {"variance": 0.028032, "average": 0.877035, "min": 0.353858}, "location": {"width": 1201, "top": 1592, "height": 41, "left": 207}, "words": "瑞格列奈的达峰时同,但不会改变格训奈的总生物利用度至相关临床范围,瑞格列奈对左诺酸生物利用"}, {"probability": {"variance": 0.031455, "average": 0.916441, "min": 0.371803}, "location": {"width": 790, "top": 1651, "height": 34, "left": 210}, "words": "度没有具临床意义的影响。但不能滁对乙炔二醇的生物利度的影响"}, {"probability": {"variance": 0.014562, "average": 0.932913, "min": 0.563215}, "location": {"width": 534, "top": 1708, "height": 31, "left": 285}, "words": "列药物可能增强和或延长装格列奈的降作用:"}, {"probability": {"variance": 0.031541, "average": 0.857172, "min": 0.38574}, "location": {"width": 1046, "top": 1763, "height": 31, "left": 262}, "words": "台贝齐,克拉素,酮唑,伊曲康坐。甲包,其他类型抗糖尿病药物:羊接化酶"}, {"probability": {"variance": 0.050526, "average": 0.81051, "min": 0.366037}, "location": {"width": 961, "top": 1818, "height": 34, "left": 212}, "words": "非选择性β父体阻滞剂,血管景张素转换酶ACE)制,酒档以及合成代的激"}, {"probability": {"variance": 0.02727, "average": 0.87054, "min": 0.551844}, "location": {"width": 438, "top": 1873, "height": 31, "left": 271}, "words": "列物可能减瑞格列奈的路血糖作用"}, {"probability": {"variance": 0.035441, "average": 0.821372, "min": 0.431567}, "location": {"width": 1151, "top": 1928, "height": 34, "left": 258}, "words": "口近孕,利祖平,苯巴比器和长马平,类药物,皮质激素,达那,甲状激杂,和拟交"}], "language": 3}